Clinical Trials Logo

Clinical Trial Summary

This is a randomized double-blind placebo controlled trial which aims to evaluate the efficacy and tolerability of minocycline and Omega-3 fatty acids for patients with ARMS. Specifically to determine whether the addition of minocycline and / or Omega-3 fatty acids to Treatment as Usual in an operationalized ARMS population in Pakistan:


Clinical Trial Description

Primary hypothesis is that the persons with ARMS who are prescribed minocycline and / or Omega-3 fatty acids will have reduced transition rates to psychosis over a one year follow up period (from baseline) compared with Treatment-As-Usual (TAU). The transition rates will be lowest in the group receiving minocycline and Omega-3 fatty acids in combination.

Secondary objective is to determine that the Persons with ARMS who are prescribed minocycline and / or Omega-3fatty acids in combination will have greatest symptom reduction compared with TAU.

This study will be a six-month intervention of minocycline and/or Omega-3 fatty acids added to TAU in patients with ARMS, using a randomised, placebo-controlled, double-blind factorial design.The study will be a four-arm trial: one arm will receive minocycline with TAU; the second arm will receive Omega-3 fatty acids with TAU; the third arm will receive both minocycline and Omega-3 fatty acids with TAU; the fourth arm will receive placebo with TAU. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02569307
Study type Interventional
Source Pakistan Institute of Learning and Living
Contact Dr.Inti Qurashi, MD
Email Inti.Qurashi@merseycare.nhs.uk
Status Recruiting
Phase Phase 2
Start date October 2015
Completion date December 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03161249 - Psychoeducative Treatment of FEP With Mobile Training N/A
Recruiting NCT02782442 - "Cognitive Training Delivered Remotely to Individuals With Psychosis N/A
Completed NCT02895269 - COllaborative Shared Care to IMprove Psychosis Outcome N/A
Recruiting NCT02733575 - Compassion Focused Therapy for Distressing Experiences N/A
Recruiting NCT02622048 - Understanding and Helping Families: Parents With Psychosis N/A
Completed NCT02653729 - Cbt for Psychosis and Affect on Psychosis Symptoms Phase 2
Completed NCT02531243 - Computer-Aided Learning for Managing Stress N/A
Not yet recruiting NCT02244970 - Mindfulness RCT for Early Psychosis N/A
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Withdrawn NCT00786318 - Ziprasidone vs Standard Therapy for Agitated Patients in the ED Phase 4
Recruiting NCT00722163 - A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis Phase 0
Completed NCT00175513 - V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis Phase 2
Completed NCT00272597 - Risperidone LA Heathcare Resource Study Phase 4
Terminated NCT00757497 - Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia Phase 1
Recruiting NCT00001247 - Inpatient Evaluation of Adults With Schizophrenia
Not yet recruiting NCT03601026 - Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use N/A
Terminated NCT00049738 - Screening for Childhood-Onset Psychotic Disorders N/A
Not yet recruiting NCT03537040 - Piloting MOL Intervention for Neuroleptic Decision Making N/A
Completed NCT02950571 - RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting N/A
Recruiting NCT02245607 - Compensatory Cognitive Training in Clinical High Risk Latino Youth N/A